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In a recent Genome Biology article,
Choe  et al. [1] describe a spike-in
experiment that they use to compare
expression measures for Affymetrix
GeneChip technology. In this work, two
sets of triplicates were created to repre-
sent control (C) and experimental (S)
samples. We describe here some prop-
erties of the Choe et al. [1] control
dataset one should consider before
using it to assess GeneChip expression
measures. In [2] and [3] we describe a
benchmark for such measures based on
experiments developed by Affymetrix
and GeneLogic. These datasets are
described in detail in [2]. A web-based
implementation of the benchmark, is
available at [4]. The experiment
described in [1] is a worthy contribu-
tion to the field as it permits assess-
ments with data that is likely to better
emulate the nonspecific binding (NSB)
and cross-hybridization seen in typical
experiments. However, there are
various inconsistencies between the
conclusions reached by [1] and [3] that
we do not believe are due to NSB and
cross-hybridization effects. In this Cor-
respondence we describe certain char-
acteristics of the feature-level data
produced by [1] which we believe
explain these inconsistencies. These
can be divided into characteristics
induced by the experimental design
and an artifact.
Experimental design
There are three characteristics of the
experimental design described by [1]
that one should consider before using it
for assessments like those carried out
by Affycomp. We enumerate them
below and explain how they may lead
to unfair assessments. Other consider-
ations are described by Dabney and
Storey [5].
First, the spike-in concentrations are
unrealistically high. In [3] we demon-
strate that background noise makes it
harder to detect differentially expres-
sion for genes that are present at low
concentrations. We point out that in
the Affymetrix spike-in experiments
[2,3] the concentrations for spiked-in
features result in artificially high inten-
sities but that a large range of the
nominal concentrations are actually in
a usable range (Figure 1a of this
Correspondence). Figure 1b demon-
strates that in a typical experiment [6],
features related to differentially
expressed genes show intensities with a
similar range as the rest of the genes -
in particular, that less than 10% of
genes, including the differentially
expressed genes, are above intensities
of 10. Figure ADF5-3 in the Additional
data files for [1] shows that less than
20% of their spiked-in gene intensities
are below 10. Additional data file 5 of
[1] also contains a reanalysis using only
the lower-intensity genes, which
provide results that agree a bit better
with results from Affycomp. A problem
is that for the Affycomp assessment
one needs to decide a priori which
genes to include in the analysis, for
example, setting a cutoff based on
nominal spike-in concentration. In the
analysis described in Additional data
file 5 of [1] one needs to choose genes a
posteriori, that is, based on observed
intensities. The latter approach can
easily lead to problems such as favoring
the inclusion of probesets exhibiting
low intensities as a result of defective
probes. Furthermore, our Figure 1c
shows that, despite the use of an
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hexperimental design that should induce
about 72% of absent genes, we observe
intensities for which the higher per-
centiles (75-95%) are twice as large as
what we observe in typical experi-
ments. This suggests that the spike-in
concentrations were high enough to
make this experiment produce atypical
data. We do not expect a preprocessing
algorithm that performs well on this
data to necessarily perform well in
general, and vice versa.
Second, a large percentage of the genes
(about 10%) are spiked-in to be differ-
entially expressed and all of these are
expected to be upregulated. This design
makes this spike-in data very different
from that produced by many experi-
ments where at least one of the follow-
ing assumptions is expected to hold: a
small percentage of genes are differen-
tially expressed, and there is a balance
between up- and downregulation.
Many preprocessing algorithms (for
example, loess normalization, variance
stabilizing normalization (VSN), rank-
invariant) implement normalization
routines motivated by one or both of
these assumptions; thus we should not
expect many of the existing expression
measure methodologies to perform
well with the Choe et al. [1] data.
Third, a careful look at Table 1 in [1]
shows that nominal concentrations and
fold-change sizes are confounded. This
problem will slightly cloud the distinc-
tion between ability to detect small fold
changes from the ability to detect dif-
ferential expression when concentra-
tion is low. Why this distinction is
important is shown in [3]. However,
Figure ADF5-1 in Additional data file 1
of Choe et al. [1] demonstrates that this
difference in nominal concentrations
does not appear to translated into
observed intensities. This could,
however, be an indication of satura-
tion, which is a common problem when
high intensities are observed (see the
first point of this argument above). One
case of the confounding is seen: genes
with nominal fold-changes larger than
1 result in intensities that, on average,
are about three times larger than genes
with nominal fold-changes of 1. 
The artifact 
Figure 1a-c of this Correspondence is
based on raw feature-level data. No pre-
processing or normalization was per-
formed. We randomly selected 100
pairs of arrays from experiments stored
in the Gene Expression Omnibus (GEO)
and without exception they produced
MA-plots similar to those seen in Figure
1a,b (MA-plots are log expression in
treatment minus (M) log expression in
control versus average (A) log expres-
sion plots). These plots have most of the
points in the lower range of concentra-
tions and an exponential tapering as
concentration increases [7]. However,
the Choe et al. [1] data show a second
cluster centered at a high concentration
and a negative log ratio. Not one of the
MA-plots from GEO looked like this.
Figure 2 in this Correspondence reveals
that the feature intensities for genes
spiked-in to be at 1:1 ratios behave very
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Figure 1
MA and cumulative distribution function (CDF) plots. MA-plots are log expression in treatment
minus (M) log expression in control versus average (A) log expression plots. (a) For two sets of
triplicates from the Affymetrix HGU133A spike-in experiment [2,3] we calculated the average log
ratio across the three comparisons (M) and the average log intensity (A) across all six arrays for each
feature. The figure shows M plotted against A. However, because there are hundreds of thousands of
features, instead of plotting each point, we use shades of blue to denote the amount of points in each
region of the plot. About 90% of the data is contained in the dark-blue regions. Orange points are
the 405 features from the 36 genes with nominal fold changes of 2. (b) As in (a) but using two sets
of biological triplicates from a study comparing three trisomic human brains to three normal human
brains. The orange dots are 385 features representing 35 genes on chromosome 21 for which we
expect fold changes of 1.5. (c) Empirical cumulative density functions for the median corrected log
(base 2) intensities of 50 randomly chosen arrays from the Gene Expression Omnibus (GEO), three
randomly selected arrays from Affymetrix HGU133A spike-in experiment, and the three S samples
from Choe et al. [1] facilitate the comparison; the intensities were made to have the same median.
The dashed black horizontal lines show the 75% and 95% percentiles. (d) As (a) but showing the two
sets of triplicates described by Choe et al. [1]. The orange dots are 375 features randomly sampled
from those that were spiked-in to have fold changes greater than 1. The yellow ellipse is used to
illustrate an artifact: among the data with nominal fold changes of 1, there appear to be two clusters
having different overall observed log ratios.
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1.0differently from the features from non-
spiked-in genes which, in a typical
experiment, exhibit, on average, log fold
changes of 0 (in practice there are
shifts, some nonlinear, but standard
normalization procedures correct this). 
This problem implies that, unless an ad
hoc correction is applied, what Choe et
al. [1] define as false positive might in
fact be true positives. Figure 2 shows that
this problem persists even after quantile
normalization [8]. In Choe et al. [1] a
normalization scheme based on knowl-
edge of which genes have fold-changes of
1 is used to correct this problem.
However, preprocessing algorithms are
not designed to work with data that has
been manipulated in this way, which
makes this dataset particularly difficult
to use in assessment tools such as Affy-
comp. Furthermore, Figure 1c,d of this
Correspondence shows that the data
produced by [1] is quite different from
data from typical experiments for
which most preprocessing algorithms
were developed.
Currently, experiments where the nor-
malization assumptions do not hold
seem to be a small minority. However,
our experience is that they are becom-
ing more common. For this type of
experiment we will need new prepro-
cessing algorithms, and the Choe et al.
[1] data may be useful for the develop-
ment of these new methods.
Additional data files 
Additional data file 1 contains MA plots
for 100 randomly chosen pairs of
arrays from the Gene Expression
Omnibus (GEO) is available online
with this Correspondence.
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Sung E Choe, Michael Boutros, Alan M
Michelson, George M Church and
Marc S Halfon respond:
Irizarry et al. raise a number of interest-
ing points in their Correspondence that
highlight the continued need for care-
fully designed control microarray
experiments. They posit that “the spike-
in concentrations are unrealistically
high” in our experimental design.
Although we have estimated that the
average per-gene concentration is
similar to that in a typical experiment
[1], we do not know individual RNA
concentrations and so cannot verify or
deny this assertion. Since the majority
of probesets in our dataset correspond
to non-spiked-in genes, and therefore
have a signal range consistent with
absent genes, we think it seems reason-
able that the spiked-in genes have
higher signal than the rest of the chip.
Regardless of this, in Additional Data
File 5 of [1], we repeated the receiver-
operator characteristics (ROC) analysis
using as the “known differentially
expressed” probe sets only the subset
with low signal levels. The results we
obtained for gcrma (robust mutli-array
average using sequence information)
[9] were very similar to the conclusions
in [3] and [10]; in addition, the perfor-
mance of MAS5 [11] was similar
between [1] and [10]. The inconsisten-
cies between the different studies may
therefore be less extreme than they
seem. In particular, we think that a
large source of the disagreement
between [1] and [3] is simply the differ-
ent choice of metric for the ROC curves.
There is no question that our analysis
of low-signal-intensity probesets as
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Figure 2
Log-ratio box-plots. (a) For the raw probe-level data in [1] we computed log fold changes comparing
the control and spike-in arrays for each of the three replicates. The C and S arrays were paired
according to their filenames: C1-S1, C2-S2, and C3-S3. Box-plots are shown for five groups of probes:
not spiked-in (gray), spiked-in at equal concentrations (purple), spiked-in with nominal fold-changes
between 1 and 2, 2 and 3, and 3 and 4 (orange). (b) As (a) but after quantile normalizing the probes.
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(a)well as the specific selection of non-dif-
ferentially expressed genes to use for
normalization purposes required prior
knowledge of the composition of the
dataset. This, of course, is one of the
great strengths of a wholly-defined
dataset such as that from [1] - we can
choose idealized conditions for assess-
ing the performance of different
aspects of the analysis. Unfortunately,
as Irizarry et al. correctly point out, it
also makes it difficult to use for certain
other types of assessment, such as
those provided by Affycomp [3].
A more critical consideration lies in the
point raised by Irizarry et al. that our
dataset violates two main assumptions
of most normalization methods: that a
small fraction of genes should be differ-
entially expressed; and that there
should be roughly equal numbers of up-
and down regulated genes. It is impor-
tant to note that these two assumptions
are just that - assumptions - and ones
that are extremely difficult to prove or
disprove in any given microarray exper-
iment. Thus there is an inherent circu-
larity in the design of analysis
algorithms that explicitly rely on these
assumptions: they perform well on data
assumed to have the properties based
on which they are designed to perform
well. This is an issue all too often over-
looked in the microarray field. The vio-
lation of these two core assumptions
seen in our dataset may be more
common than generally appreciated;
certainly we can conceive of many situa-
tions in which they are unlikely to hold
(for example, when comparing different
tissue types, in certain developmental
time courses, or in cases of immune
challenge). Developing assumption-free
normalization methods, and diagnostics
to assess the efficacy of the normaliza-
tion used for a given dataset (see [12]
for an example), should thus be impor-
tant research priorities.
This discussion underscores the need
for more control datasets that specifi-
cally address matters of RNA concen-
tration, fractions of differentially
expressed genes, direction of changes
in gene regulation, and the like. Only
then can we truly devise and assess the
performance of analysis methods for
the large variety of possible scenarios
encountered in the course of conduct-
ing microarray experiments focused on
real biological problems.
Correspondence should be sent to Marc
S Halfon: Department of Biochemistry
and Center of Excellence in Bioinfor-
matics and the Life Sciences, State Uni-
versity of New York at Buffalo, Buffalo,
NY 14214, USA. Email:
mshalfon@buffalo.edu
References
1. Choe SE, Boutros M, Michelson AM,
Church GM, Halfon MS: Preferred
analysis methods for Affymetrix
GeneChips revealed by a wholly
defined control dataset. Genome Biol
2005, 6:R16.
2. Cope L, Irizarry R, Jaffee H, Wu Z, Speed
T:  A benchmark for Affymetrix
GeneChip expression measures. Bioin-
formatics 2004, 20:323–331.
3. Irizarry R, Wu Z, Jaffee H: Comparison of
Affymetrix GeneChip expression mea-
sures. Bioinformatics 2006, 22:789-794.
4. Affycomp II:  A benchmark for
Affymetrix GeneChip expression
measures
[http:affycomp.biostat.jhsph.edu]
5. Dabney A, Storey J: A reanalysis of a
published Affymetrix GeneChip
control dataset. Genome Biol 2006,
7:401.
6. Saran NG, Pletcher MT, Natale JE, Cheng
Y, Reeves RH: Global disruption of the
cerebellar transcriptome in a Down
syndrome mouse model. Hum Mol
Genet 2003, 12:2013-2019.
7. One hundred MA plots from GEO
[http://www.biostat.jhsph.edu/~ririzarr/
papers/hundredMAs.pdf] 
8. Bolstad B, Irizarry R, Åstrand M, Speed T:
A comparison of normalization
methods for high density oligonu-
cleotide array data based on variance
and bias. Bioinformatics 2003, 19:185-193.
9. Wu Z, Irizarry R, Gentleman RC, Mar-
tinez-Murillo F, Spencer F: A model-
based background adjustment for
oligonucleotide expression arrays.
Journal of the American Statistical Association
2004, 99:909-917.
10. Qin LX, Beyer RP, Hudson FN, Linford NJ,
Morris DE, Kerr KF: Evaluation of
methods for oligonucleotide array
data via quantitative real-time PCR.
BMC Bioinformatics 2006, 7:23.
11. GeneChip Expression Analysis: data
analysis fundamentals 
[http://www.affymetrix.com/support/
downloads/manuals/data_analysis_
fundamentals_manual.pdf]
12. Gaile DP, Miecznikowski JC, Choe SE,
Halfon MS: Putative null distributions
corresponding to tests of differential
expression in the Golden Spike
dataset are intensity dependent.
Technical report 06-01. Buffalo, N.Y.:
Department of Biostatistics, State Univer-
sity of New York; 2006,
[http://sphhp.buffalo.edu/biostat/research/
techreports/UB_Biostatistics_TR0601.pdf].
404.4 Genome Biology 2006, Volume 7, Issue 8, Article 404 Irizarry et al.                                                         http://genomebiology.com/2006/7/8/404
Genome Biology 2006, 7:404